Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
application process for a fixed term of four years. The tenure track system offers researchers a possibility to advance to the next level, provided they meet the requirements in the promotion reviews
-
. There will be a six-month trial period for the position. The appointee will be responsible for teaching in Russian as the first language in the Bachelor’s Programme in Languages. They will also give courses in
-
track and will be filled through an open application process for a fixed term of four years (assistant/associate professor) or permanently (full professor). The tenure track system offers researchers a
-
. The role includes teaching in the Bachelor’s Programme in the Languages and Literatures of Finland, the Master’s Programme in Finnish and Finno-Ugrian Studies, the Master’s Programme in Linguistic Diversity
-
the candidate can start in autumn 2025. Background Our group develops and applies systems pharmacology strategies to design rational combinatorial therapies for cancer. We combine both computational (dry-lab) and
-
Wellbeing Across Lifespan (SWAN) brings together expertise from the fields of medicine, life sciences, social sciences as well as computer and computational sciences to promote scientific and societal impact
-
tools. We additionally value expertise in behavioral measurements, neurostimulation, or computational modelling. While the scope of the position is broad, the new professor is expected to have a strong
-
computational problems and not the publication process. Open Source is our expectation. All (or most) of your code may be open source and may be added to your public CV, depending on the needs of researchers
-
computational problems and not the publication process. Open Source is our expectation. All (or most) of your code may be open source and may be added to your public CV, depending on the needs of researchers
-
is decoded through transcription, and how the defects in this process can be used as a basis for therapy. Currently, we are probing how the crosstalk between transcriptional kinases and other factors